Phenotype measures directly associated with ontology term
VT:0006387   'T cell quantity'        
Navigate ontologies  
This list only includes measures mapped to VT:0006387 directly. Measures mapped to its ontology descendants are not included. Alternatively, you can show measures mapped to VT:0006387 AND its descendants.
Sort/
Pick
Data set
Procedure / Protocol
Treatment
Phenotype Measure / Variable (click to view)
Panel
No. of Strains
Sex
Age
Sample Size (Avg)
Year
    Donahue5 immune cell quantification (none) T cells (percentage of viable WBC)   [%]  pct_T_cells   41409 B6.A consomic w/par 22 both 7wks N=8 2011
    Donahue6 immune cell quantification (none) T cells (percentage of viable WBC)   [%]  pct_T_cells   41509 B6.PWD consomic w/par 28 both 7wks N=8 2011
    Graham3 immune cell quantification (none) percentage of splenic lymphocytes that are CD3+ T cells (memory precursor panel)   [%]  mp_CD3_pos   113812     CC RIX 92 m 8-10wks N=4 2021
    Graham3 immune cell quantification (none) percentage of splenic lymphocytes that are CD3+ T cells (memory panel)   [%]  mem_CD3_pos   113825     CC RIX 68 m 8-10wks N=3 2021
    Graham3 immune cell quantification (none) percentage of splenic lymphocytes that are CD3+ T cells following stimulation with anti-CD3 and anti CD28   [%]  ics_CD3_pos   113838     CC RIX 102 m 8-10wks N=4 2021
    Lesage1 immune cell quantification (none) percentage of splenic lymphocytes that are T cells   [%]  T_cells   63515 CC w/par 76 both 5-8wks N=2 2018
    Wiltshire4 immune cell quantification BEZ235 T cells, percent viability   [%]  Tcells_BEZ   52407     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 34 m 10wks N=4 2015
    Wiltshire4 immune cell quantification doxorubicin T cells, percent viability   [%]  Tcells_Dox   52427     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 35 m 10wks N=4 2015
    Wiltshire4 immune cell quantification idarubicin T cells, percent viability   [%]  Tcells_Ida   52447     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 35 m 10wks N=4 2015
    Wiltshire4 immune cell quantification selumetinib T cells, percent viability   [%]  Tcells_Sel   52467     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 34 m 10wks N=4 2015
    All boxes            


  •   Or, add these measures to your collection.
       
  •     no folder
  •     put them in new folder